Single-Cell RNA Sequencing Reveals Extensive Heterogeneity and Unique Gene Trajectories in Non-Transformed and Transformed Human Lung Epithelial Cells: Insights into the Role of LncRNAs in Tumor Heterogeneity
International Journal of Molecular Sciences · 16.02.2025 · 26 (4) · 1690
DOI: 10.3390/ijms26041690 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.02.2025. Verfasst von Sokviseth Moeng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Genomic and Precision Medicine, Texas A&M Institute of Biosciences and Technology, Texas Medical Center, Houston, TX 77030, USA. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Single-Cell Analysis, Epithelial Cells, Lung Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, NIH HHS, GURI Award from the State of Texas.
Abstract (Originalsprache)
Lung cancer exhibits substantial inter- and intra-tumor heterogeneity, with features that present significant challenges in advancing biomarker discovery and the development of targeted therapeutics. To fill this gap, we employed single-cell RNA sequencing (scRNA-seq) and advanced bioinformatics tools to evaluate the transcriptomic heterogeneity of immortalized, non-transformed (BEAS2B) and transformed (H460) lung epithelial cell lines and their responses to carcinogen challenge. Gene expression profiles resolved four primary clusters further discretized into unique subclusters based on genetic signatures and phenotypic profiles. Profiles of long non-coding RNAs (lncRNAs) identified microRNA host genes, antisense RNA genes, divergent transcript, and long intergenic non-coding RNAs as contributors to cellular heterogeneity. These findings indicate that distinct patterns of gene expression, remarkably in lncRNAs, define cellular heterogeneity in non-transformed versus transformed cells. These features can be exploited for the development of therapies directed at specific cell subpopulations in precancerous lesions and within lung tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Genomic and Precision Medicine, Texas A&M Institute of Biosciences and Technology, Texas Medical Center, Houston, TX 77030, USA.
- Center for Epigenetics and Disease Prevention, Texas A&M Institute of Biosciences and Technology, Texas Medical Center, Houston, TX 77030, USA.
- Department of Veterinary Integrative Biosciences, Texas A&M University, College Station, TX 77843, USA.
ORCID-Profile: Sokviseth Moeng, Andres D Chamorro-Parejo, James J Cai, Kenneth S Ramos
Förderung
- NIEHS NIH HHS
- NIH HHS
- GURI Award from the State of Texas
- NIH
Zitieren
APA
Moeng, S., Chamorro-Parejo, A. D., Jeon, M. S., Cai, J. J., & Ramos, K. S. (2025). Single-Cell RNA Sequencing Reveals Extensive Heterogeneity and Unique Gene Trajectories in Non-Transformed and Transformed Human Lung Epithelial Cells: Insights into the Role of LncRNAs in Tumor Heterogeneity. International Journal of Molecular Sciences, 26(4), 1690. https://doi.org/10.3390/ijms26041690
Vancouver
Moeng S, Chamorro-Parejo AD, Jeon MS, Cai JJ, Ramos KS. Single-Cell RNA Sequencing Reveals Extensive Heterogeneity and Unique Gene Trajectories in Non-Transformed and Transformed Human Lung Epithelial Cells: Insights into the Role of LncRNAs in Tumor Heterogeneity. International Journal of Molecular Sciences. 2025;26(4):1690. doi:10.3390/ijms26041690
BibTeX
@article{Moeng2025,
author = {Moeng, Sokviseth and Chamorro-Parejo, Andres D and Jeon, Minsun S and Cai, James J and Ramos, Kenneth S},
title = {Single-Cell RNA Sequencing Reveals Extensive Heterogeneity and Unique Gene Trajectories in Non-Transformed and Transformed Human Lung Epithelial Cells: Insights into the Role of LncRNAs in Tumor Heterogeneity},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {4},
pages = {1690},
doi = {10.3390/ijms26041690}
}
EUVIMED